October 10, 2011
Mitsubishi Tanabe Pharma Corporation (MTPC) announced on September 26 that it received marketing approval on the same day for the chronic hepatitis C treatment Telavic 250 mg Tablet (telaprevir). The company plans to launch the product as soon as possible...read more